Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.

Mameli G, Arru G, Caggiu E, Niegowska M, Leoni S, Madeddu G, Babudieri S, Sechi G P, Sechi LA

PLoS One. 2016; 11(6):e0157153. Epub 2016 Jun 16. PMID: 27310932. Abstract